SMTL ID : 3bym.1

X-ray co-crystal structure aminobenzimidazole triazine 1 bound to Lck

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

2 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 3 residues within 4Å: Chain A: G.227, Y.228, R.229 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:R.229 Water bridges: A:Y.241, A:Y.241 SO4.2: 3 residues within 4Å: Chain A: T.101, P.102, S.103 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:T.101, A:S.103, A:S.103 Water bridges: A:S.103, A:S.103

1 x AM0: N-phenyl-1-{4-[(3,4,5-trimethoxyphenyl)amino]-1,3,5-triazin-2-yl}-1H-benzimidazol-2-amine(Non-covalent)

AM0.3: 17 residues within 4Å: Chain A: L.22, V.30, A.42, K.44, E.59, M.63, V.72, T.87, E.88, Y.89, M.90, E.91, G.93, S.94, L.142, A.152, D.153 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:V.30, A:V.30, A:K.44, A:V.72, A:Y.89, A:A.152 Hydrogen bonds: A:T.87, A:M.90, A:M.90, A:S.94 Water bridges: A:D.97, A:D.97, A:D.153

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Martin, M.W. et al., Structure-based design of novel 2-amino-6-phenyl-pyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones as potent and orally active inhibitors of lymphocyte specific kinase (Lck): synthesis, SAR, and in vivo anti-inflammatory activity. J.Med.Chem. (2008)

Release Date

2008-09-16

Peptides

Proto-oncogene tyrosine-protein kinase LCK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Proto-oncogene tyrosine-protein kinase LCK